Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin vs linezolid CSF PK/PD after neurosurgery
ChiCTR2100044495Phase 4Recruiting
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Mar 2021
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of vancomycin and linezolid in intracranial infection and surgical site infection (SSI) (4 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoints: Cerebrospinal fluid drug concentration, Blood drug concentration and 1 more. Started Mar 2021; status: recruiting.
02
Drugs
vancomycinlinezolid
03
Conditions
intracranial infectionsurgical site infection (SSI)
Beyond the preview
Go deeper on ChiCTR2100044495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044495.